Methods and systems for treating cell proliferation disorders with psoralen derivatives
US-11452884-B2 · Sep 27, 2022 · US
This page is not indexed by search engines while we improve data quality.
Gooden David patents
Gooden David is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Gooden David |
| Total patents | 8 |
| First publication | Jul 23, 2015 |
| Latest publication | Sep 27, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Choline Esters
US-2022151988-A1 · May 19, 2022 · US
Method of treating presbyopia using dithiol compounds and their derivatives
US-10039743-B2 · Aug 7, 2018 · US
Methods and systems for treating cell proliferation disorders with psoralen derivatives
US-2018169433-A1 · Jun 21, 2018 · US
Methods and systems for treating cell proliferation disorders with psoralen derivatives
US-2017113061-A1 · Apr 27, 2017 · US
Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
US-2016331731-A1 · Nov 17, 2016 · US
Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
US-9439897-B2 · Sep 13, 2016 · US
Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
US-2015202294-A1 · Jul 23, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Immunolight Llc | 6 |
| Univ Duke | 6 |
| Novartis Ag | 2 |
| Encore Health Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 5 |
| A61K31/37 | 5 |
| A61K45/06 | 4 |
| A61K31/517 | 3 |
| A61K41/0066 | 3 |